6 May 2019
How we can create a more ambitious, more radical (and maybe even more optimistic) view of the low-carbon future.
Tackling global challenges, one issue at a time. From energy and the environment to economics, development and global health, our expert contributors look at all angles. ANGLE focuses on the intersection of science, policy and politics in an evolving and complex world.
Brought to you from the team at Imperial College's A Global Village.
The 'lost generation' refers to mid-career researchers that, after completing many temporary positions, find themselves largely excluded from research careers. How do we address this growing issue?
What challenges do women in male dominated research areas face and what can we all do to increase the presence of women and other minorities in these fields?
European research funding is unevenly distributed. The success of the upcoming funding programme Horizon Europe hinges on how well it manages to overcome the geopolitical differences around the continent that have created this inequality. To realize Europe's full research potential, diverse contributions and widening participation must be recognized as an integral part of research excellence.
If Maria Emilia is a Latin American scientist, half of her colleagues are probably also women, but her chance of being admitted to the National Academy or National Agency is much lower than for her male colleagues. What are the main challanges women in science face in Latin America and the Caribbean? And what policies would (or should) support them?
15 October 2018
Transport accounts for a quarter of global carbon dioxide emissions and remains one of few sectors where emissions are still growing. A key challenge is determining the relative importance of pursuing a technological or a sociological solution: should we change transportation or the behaviour of people?
Around 700,000 lives are lost worldwide due to antimicrobial-resistant infections every year. Without viable antibiotic treatment options we are likely to return to a relative dark age of medicine – a time when common infections or injuries could kill, and common surgeries and immunosuppressive therapies may become unfeasible.
A political drive in the UK is leading to undermining of access to primary and emergency care for many vulnerable groups despite evidence of potential harm to individual and public health. Bringing little if any economic benefit, the policy to introduce charges for primary care and A&E for visitors and migrants is progressing at pace while critics of the policy are side-lined.
DNA sequencing is an exciting modern technology, that has vastly improved our ability to treat infections. However antibiotic resistance is a growing problem and DNA sequencing is revealing the challenge we face as bacteria are rapidly evolving resistance to antibiotics.
The new EU27 must look beyond itself and focus on relevant global challenges, which are greater than internal difficulties.
If Brexit happens, the UK will not be in a strong position to face global challenges. Lagging in trade openness and innovation, and facing a divergent regulatory environment and declining foreign investment, the UK will struggle to re-negotiate trade deals with global partners. Conversely, as the influence of the EU moves east, increased political coherence could benefit the Euro and EU financial sector.
The rules no longer apply. The biggest challenge facing the new EU is the growing threat to the international economic order. From banking to free movement of people and goods to international law and trade, bilateral alliances and unilateral moves have undermined existing structures. As Brexit heats up, a new 2-part series from trade expert Eoin Gahan will explore its trade and investment prospects.
Astronauts survive in space by utilizing protective and augmentative suits. Space suits can act as self-contained and self-cleaning environments, that protect and help the astronaut from the harshness of space. Scaling analogous suits down to the nanoscale allows for simple organisms to survive and even thrive in normally toxic environments. These augmented organisms are termed “bionic lifeforms” as they combine the promise of nanomaterials with life.
50 years after it was first proposed, gene therapy - the modification of DNA to treat disease - has gone from science fiction to clinical reality. However, as prices for gene therapies are released, widespread sticker-shock is raising questions about affordability and fair pricing.
For years scientists have been studying E. coli as historians would an ancient tome. Biologists, biochemists, and geneticists have dissected, poked, and prodded E. coli until it gave up its secrets: the basic principles of cellular life. Synthetic biologists, on the other hand, look at E. coli and think to themselves: “let’s make a computer”.
Get our latest articles straight to your inbox!
Copyright 2015 ANGLE Journal